TSCAN THERAPEUTICS, INC. (TCRX) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 30.96M USD | Liabilities, Current |
| Cash and equivalents | 100.16M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $30.96M | $100.16M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $19.97M | $128.06M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $18.70M | $152.41M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $29.21M | $169.51M | $14.95M | (m) | (m) | (m) |
| 2025-06-30 | (m) | $31.32M | $169.39M | $48.65M | (m) | (m) | (m) |
| 2025-03-31 | (m) | $29.82M | $154.11M | $97.58M | (m) | (m) | (m) |
| 2024-12-31 | (m) | $35.96M | $178.69M | $111.42M | (m) | (m) | (m) |
| 2024-09-30 | (m) | $28.66M | $133.12M | $138.00M | (m) | (m) | (m) |
| 2024-06-30 | (m) | $38.57M | $242.16M | $55.52M | (m) | (m) | (m) |
| 2024-03-31 | (m) | $31.48M | $140.51M | $22.27M | (m) | (m) | (m) |
| 2023-12-31 | (m) | $29.82M | $133.36M | $58.69M | (m) | (m) | (m) |
| 2023-09-30 | (m) | $33.15M | $155.19M | $60.23M | (m) | (m) | (m) |
| 2023-06-30 | (m) | $35.12M | $208.84M | (m) | $31.93M | (m) | (m) |
| 2023-03-31 | (m) | $14.05M | $95.61M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $17.30M | $120.03M | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $16.59M | $137.31M | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $17.17M | $125.60M | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $18.46M | $140.84M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $21.34M | $161.41M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $22.94M | $182.31M | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $20.62M | $106.20M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | $121.50M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $17.45M | $34.79M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |